News in brief

Nutrasource rebrands clinical trial site to Apex Trials

 © VeranoVerde / Getty Images
© VeranoVerde / Getty Images

Related tags CRO CRO

Canadian CRO Nutrasource Pharmaceutical and Nutraceutical Services Inc has rebranded its clinical trial site as Apex Trials to expand its focus beyond food & natural health product trials.

According to a press release, the primary focus of Apex Trials is Phase I / Pharmacokinetic studies – Phase IV Studies for both pharmaceutical and nutraceuticals targeting a range of indications, including: Cardiovascular Disease, Hypertension, Dyslipidemia, Diabetes, Irritable bowel syndrome, and Weight management.

"Over the past decade, I have been able to witness and appreciate the evolution of our clinical trials unit,” ​said Katie Keene, Clinic Supervisor.  “This latest change is our biggest and best yet as it will allow us to expand our focus beyond food and natural health product trials to include pharmaceutical trials, further growing our site’s portfolio of offerings.”

Apex Trials operates a 17,000 sq ft clinical trial suite under the leadership of Principal Investigator Dr. Anthony Bier, and is headquartered in Southwestern Ontario, Canada.

“We are excited to launch our clinical trial site under the brand of Apex Trials,”​ added Joshua Baisley, SVP Clinical Operations. “We deliberately separated the operations of our site from our CRO activities many years ago to differentiate ourselves from our competitors and demonstrate our commitment to compliance thereby protecting our Sponsor’s investment. With a team of over 20 staff, 20 years of clinical trial experience, and a client-centric approach.”

Related topics Clinical Development Phase I-II

Related news

Related products

show more

Are You Prepared to Meet the New FDA Guidelines?

Are You Prepared to Meet the New FDA Guidelines?

Elligo Health Research® | 23-Mar-2023 | Insight Guide

On April 15, 2022, the U.S. Food and Drug Administration issued a new draft guidance to clinical research sponsors on creating a plan to enroll more participants...

ODM and CDASH in CRF design

ODM and CDASH in CRF design

Formedix | 10-Mar-2023 | Technical / White Paper

The lesser-known Operational Data Model (ODM) standard is often overlooked as it's not required by any regulators. So, why should you be interested...

How Sponsors Reduce Chaos in Decentralized Trials

How Sponsors Reduce Chaos in Decentralized Trials

Florence Healthcare | 08-Mar-2023 | Insight Guide

89% of research sponsors currently use and expect to continue the use of decentralized technologies and methods, according to our state of the industry...

2023 State of Clinical Trial Technology Report

2023 State of Clinical Trial Technology Report

Florence Healthcare | 01-Mar-2023 | Insight Guide

Discover the trends shaping clinical trial technology in 2023, from Site Enablement to eISFs, integrations, and site-sponsor collaboration. This report...

Related suppliers

Follow us


View more